Document:

<PAGE>   1
                                                                    Exhibit 10.4

Distribution Agreement between SmartSources.com Technologies Inc. and kTravel
Solutions Inc. (The entire document has been omitted and filed separately with
the commission, requesting confidential treatment).<PAGE>   1
FAX TRANSMISSION-3 PAGES
ORIGINAL DELIVERED BY U.S. MAIL

June 30, 2000

Mr. James A. Richman
Chief Financial Officer
SpaceLabs Medical
15220 N.E. 40th Street
P.O. Box 97013
Redmond, WA  98073-9713
FAX: 425-885-4877

Dear Jim:

We are pleased to propose the following terms associated with the requested
restructure of the financial covenants and extension of the revolving periods.
With the exception of the specific items listed below, all of the terms and
conditions of the existing loan agreement dated July 16, 1997, as subsequently
amended, will remain in full force and effect.

Amendment
of Financial Covenants:      The requirement to comply with Sections 5.11
                             (Funded Debt to EBITDA Ratio) and 5.12 (EBITDA to
                             Debt Service Ratio) will not be measured as of June
                             30, 2000 and September 30, 2000. With respect to
                             the forgoing covenants, the calculation of EBITDA
                             for ensuing quarters will be amended as follows:
                             for the quarter ended December 31, 2000, EBITDA
                             shall be computed using four times the EBITDA for
                             such quarter; for the quarter ended March 31, 2001,
                             EBITDA shall be computed using three times the
                             EBITDA for the quarter ended March 31, 2001 plus
                             the EBITDA for the quarter ended December 31, 2000;
                             for the quarter ended June 30, 2001, EBITDA shall
                             be computed using two times the EBITDA for the
                             quarter ended June 30, 2001 plus the EBITDAs for
                             the quarters ended December 31, 2000 and March 31,
                             2001. As of September 30, 2001, a trailing four
                             quarters calculation of EBITDA shall resume.

                             For purposes of calculating compliance with Section
                             5.12, the CPLTD that is associated with the balloon
                             payment due on the Term Loan (see below) during
                             December 2003, and which will first appear as a
                             part of CPLTD on March 31, 2003, will not be
                             included in the determination of the Debt Service
                             Ratio.

                             With respect to Section 5.13 (Tangible Net Worth),
                             the initial required TNW shall be $135,000,000 as
                             of the quarter ended June 30, 2000, with all other
                             terms under Section 5.13 (required step-ups in the
                             required TNW, etc.) remaining unchanged.

                             Section 6.5 shall be revised to introduce the
                             requirement that SpaceLabs earn at least one dollar
                             of net income in each fiscal year. For the year
                             ended December 31, 2000, the requirement to earn
                             one dollar of net income will only pertain to the
                             fourth quarter ended December 31, 2000. Any
                             existing language that is contrary to this new
                             requirement will be either eliminated or amended.

New Financial Covenant:      Fixed Charge Coverage Ratio no lower than 1.10:1.
                             For the quarter ended September 30, 2000, EBITDA
                             shall be computed using four times the EBITDA for
                             such quarter. Beginning with the quarter ended
                             December 31, 2000, EBITDA will be calculated in a
                             manner consistent with that pertaining to

<PAGE>   2
Mr. Jim Richman
SpaceLabs Medical
June 30, 2000

                             Sections 5.11 and 5.12 as described in the second
                             paragraph of this letter. The definition of Fixed
                             Charge Coverage shall mean EBITDA less Cash Taxes
                             less unfinanced CAPEX less Cash Dividends divided
                             by Interest plus MDR.

Maturity:                    The revolving commitment maturity of the Revolving
                             Note will be extended from July 16, 2000 to July
                             16, 2005. The Revolving Note will not include a
                             term-out option. The maturity of the revolving
                             commitment of the Burdick Note will be extended
                             from July 16, 2000 to July 16, 2001. Per the terms
                             of the Burdick Note, the term repayment period will
                             commence on July 16, 2001 and extend for five years
                             beyond July 16, 2001. Principal repayment terms
                             will remain as scheduled, except that principal
                             repayment in the first four quarters of the
                             term-out period will total $3MM (paid in equal
                             amounts each quarter), while the principal payments
                             due in the last four quarters of the term-out
                             period will total $9MM (paid in equal amounts each
                             quarter).

                             In addition to the aforementioned, the final
                             maturity of the existing Term Loan (loan
                             outstanding equal to approximately $11.5MM) will be
                             extended for one year to December 2003. Principal
                             amortization during the "extension year" will equal
                             the amount paid historically.

Collateral:                  A first security interest in the A/Rs, and
                             Inventory of Borrower and its principal
                             subsidiaries will be granted. In addition, a first
                             deed of trust in the Redmond, headquarters real
                             estate (headquarters building and manufacturing
                             site) will be granted; but the loan documentation
                             shall contain a proviso which will permit SpaceLabs
                             to convey the property to a wholly-owned subsidiary
                             subject to all of the conditions of the deed of
                             trust.

Up-front Fee:                45 basis points on the $75,000,000 cumulative
                             commitment for the Revolving and Burdick Notes.

Pricing Grid:                For the Revolving and Burdick Notes, all of the
                             existing borrowing spreads will be replaced by the
                             following grid:

<TABLE>
<CAPTION>
                                    Funded Debt/   Borrowing     Fee on
                                    EBITDA*        Spread        Unused
                                    -------        ------        ------
<S>                                 <C>            <C>           <C>
                                    >= 4.0X         250bp         60bp
                                    >= 3.5X         225           60
                                    >= 3.0X         200           60
                                     < 3.0X         150           60
</TABLE>

                             *Measured in a manner consistent with the covenant
                             calculation described above.

                             For the quarters ended September 30 and December
                             31, 2000, the Borrowing Spread will be 250bp. With
                             respect to the Term Loan, the borrowing spread will
                             be increased to LIBOR + 150bp for the life of the
                             loan.

Final Execution:             Final credit approval for this proposal has been
                             obtained at both, Bank of America and U.S. Bank.
                             Therefore, the foregoing is a binding commitment
                             that extends to both Banks and Borrower subject to
                             the successful negotiation and execution of final
                             loan documents reflecting the conditions addressed
                             herein.

ORAL AGREEMENTS OR ORAL COMMITMENTS TO LOAN MONEY, EXTEND CREDIT OR TO FORBEAR
FROM ENFORCING PAYMENT OF THE DEBT ARE NOT ENFORCEABLE UNDER

<PAGE>   3
Mr. Jim Richman
SpaceLabs Medical
June 30, 2000

WASHINGTON LAW R.C.W. 19.26.

Jim, we look forward to working with you on this request. Please call me with
any questions and/or comments you might have.

Sincerely,

Dora Brown

cc:
 Scott Stewart, SpaceLabs Medical
 Hank Knottnerus, Bank of America
 Larry Davis, Bank of America
 Jim Lawrence, U.S. Bank
 Wilfred Jack, U.S. Bank

ACCEPTED BY:

                                (Name, Title---Printed)
-------------------------------

                               (Signature)
-------------------------------

                                (Date)
-------------------------------<PAGE>   1

                         LIFECLINIC HOLDING CORPORATION
                         2000 LONG - TERM INCENTIVE PLAN

       1. Definitions. In this Plan, except where the context otherwise
indicates, the following definitions shall apply:

              1.1. "Affiliate" means Spacelabs or a corporation, partnership,
business trust, limited liability company or other form of business organization
at least a majority of the total combined voting power of all classes of stock
or other equity interests of which is owned by the Company or Spacelabs, either
directly or through one or more other Affiliates.

              1.2. "Agreement" means a written agreement evidencing an Award.

              1.3. "Award" means a grant of an Option, Right or Performance
Award or an award of Restricted Stock or Incentive Share Awards.

              1.4. "Board" means the Board of Directors of the Company.

              1.5. "Code" means the Internal Revenue Code of 1986, as amended.

              1.6. "Committee" means the Compensation Committee of the Board of
Directors of Spacelabs or such person(s), committee(s) or subcommittee(s)
appointed by the Board of Directors of the Company to administer this Plan, or
portions thereof, or to make and/or administer specific Awards hereunder. If no
such appointment is in effect at any time, "Committee" shall mean the Board of
Directors of the Company.

              1.7. "Common Stock" means the common stock, par value $.01 per
share, of the Company.

              1.8. "Company" means Lifeclinic Holding Corporation, a Washington
corporation, and any successor thereto.

              1.9. "Date of Exercise" means the date on which the Company
receives notice of the exercise of an Option or Right in accordance with the
terms of Section 8.1.

              1.10. "Date of Grant" means the date on which an Award is granted
under this Plan.

              1.11. "Eligible Person" means any person who is (a) an Employee
(b) hired to be an Employee, (c) a Non-Employee Director or (d) a consultant or
independent contractor to the Company or an Affiliate and who is determined by
the Committee to render key services to the Company or an Affiliate.

              1.12. "Employee" means any person determined by the Committee to
be an employee of the Company or an Affiliate.

<PAGE>   2

              1.13. "Exchange Act" means the Securities Exchange Act of 1934, as
amended.

              1.14. "Fair Market Value" means an amount equal to the then fair
market value of a Share as determined by the Committee pursuant to a reasonable
method adopted in good faith for such purpose, or, unless otherwise determined
by the Committee, if the Shares become registered under the Securities Act of
1933, as amended and the Shares are traded on a securities exchange or automated
dealer quotation system, fair market value shall be the last sale price for a
Share, as of the relevant date, on such securities exchange or automated dealer
quotation system as reported by such source as the Committee may select.

              1.15. "Incentive Share Award" means an award providing for the
contingent grant of Shares pursuant to the provisions of Section 10.

              1.16. "Incentive Stock Option" means an Option granted under this
Plan that the Company designates as an incentive stock option under Section 422
of the Code.

              1.17. "Non-Employee Director" means any member of the Company's or
an Affiliate's Board of Directors who is not an Employee.

              1.18. "Nonstatutory Stock Option" means an Option granted under
this Plan that is not an Incentive Stock Option.

              1.19. "Option" means an option to purchase Shares granted under
this Plan in accordance with the terms of Section 6.

              1.20. "Option Period" means the period during which an Option may
be exercised.

              1.21. "Option Price" means the price per Share at which an Option
may be exercised.

              1.22. "Participant" means an Eligible Person who has received an
Award hereunder.

              1.23. "Performance Award" means a performance award granted under
the Plan in accordance with the terms of Section 11.

              1.24. "Performance Goals" means performance goals established by
the Committee which may be based on earnings or earnings growth, sales, return
on assets, cash flow, total shareholder return, equity or investment, regulatory
compliance, satisfactory internal or external audits, improvement of financial
ratings, achievement of balance sheet or income statement objectives, or any
other objective goals established by the Committee, and may be absolute in their
terms or measured against or in relationship to other companies comparably,
similarly or otherwise situated. Such performance standards may be particular to
an Eligible Person, the Company, or the department,

                                       2
<PAGE>   3

branch, Affiliate or other division in which he or she works, or may be based on
the performance of the Company or the Company and its Affiliates generally, and
may cover such period as may be specified by the Committee.

              1.25. "Plan" means the Lifeclinic Holding Corporation 2000
Long-Term Incentive Plan, as amended from time to time.

              1.26. "Related Option" means an Option in connection with which,
or by amendment to which, a specified Right is granted.

              1.27. "Related Right" means a Right granted in connection with, or
by amendment to, a specified Option.

              1.28. "Restricted Stock" means Shares awarded under the Plan
pursuant to the provisions of Section 9.

              1.29. "Right" means a stock appreciation right granted under the
Plan in accordance with the terms of Section 7.

              1.30. "Right Period" means the period during which a Right may be
exercised.

              1.31. "Share" means a share of Common Stock.

              1.32. "Spacelabs" means Spacelabs Medical, Inc., a Delaware
corporation.

              1.33. "Ten-Percent Stockholder" means a Participant who (applying
the rules of Section 424(d) of the Code) owns stock possessing more than 10% of
the total combined voting power of all classes of stock of the Company or an
Affiliate.

       2. Purpose. This Plan is intended to assist the Company and its
Affiliates in attracting and retaining Eligible Persons of outstanding ability
and to promote the identification of their interests with those of the
stockholders of the Company and its Affiliates.

       3. Administration. The Committee shall administer this Plan and shall
have plenary authority, in its discretion, to grant Awards to Eligible Persons,
subject to the provisions of this Plan. The Committee shall have plenary
authority and discretion, subject to the provisions of this Plan, to determine
the Eligible Persons to whom Awards shall be granted, the terms (which terms
need not be identical) of all Awards, including without limitation the Option
Price of Options, the time or times at which Awards are made, the number of
Shares covered by Awards, whether an Option shall be an Incentive Stock Option
or a Nonstatutory Stock Option, any exceptions to non-transferability, any
Performance Goals applicable to Awards, any provisions relating to vesting, and
the period during which Options and Rights may be exercised. In making these
determinations, the Committee may take into account the nature of the services
rendered

                                       3
<PAGE>   4

or to be rendered by the Award recipients, their present and potential
contributions to the success of the Company and its Affiliates, and such other
factors as the Committee in its discretion shall deem relevant. Subject to the
provisions of the Plan, the Committee shall have plenary authority to interpret
the Plan, prescribe, amend and rescind rules and regulations relating to it, and
make all other determinations deemed necessary or advisable for the
administration of this Plan. The determinations of the Committee on the matters
referred to in this Section 3 shall be binding and final.

       4. Eligibility. Awards may be granted only to Eligible Persons; provided,
however, that Incentive Stock Options may not be granted to Eligible Persons who
are not employed by the Company or a "percent corporation" or a "subsidiary
corporation" as defined in Section 424(e) or (f) of the Code (but substituting
"the Company" for "employer corporation").

       5. Stock Subject to the Plan and Awards Under the Plan.

              5.1. Shares Available for Issuance. Subject to adjustment as
provided in Section 12, the maximum number of Shares with respect to which
Awards may be issued under this Plan is 1,904,000 Shares; provided, however,
that if an Option or Right expires or terminates for any reason (other than
termination by virtue of the exercise of a Related Option or Related Right, as
the case may be) without having been fully exercised, if Shares of Restricted
Stock are forfeited or if Shares covered by an Incentive Share Award or
Performance Award are not issued or are forfeited, the unissued or forfeited
Shares that had been subject to the Award shall become available for issuance
pursuant to the terms of other Awards.

              5.2. Limitations on Awards. Notwithstanding Section 5.1, the
maximum number of Shares with respect to which an Eligible Person may be granted
Awards under this Plan during any three year period is 1,000,000 Shares.

       6. Options.

              6.1. Options granted under this Plan to Eligible Persons shall be
either Incentive Stock Options or Nonstatutory Stock Options, as designated by
the Committee. Each Option granted under this Plan shall be clearly identified
either as a Nonstatutory Stock Option or an Incentive Stock Option and shall be
evidenced by an Agreement that specifies the terms and conditions of the grant.
Options shall be subject to the terms and conditions set forth in this Section 6
and such other terms and conditions not inconsistent with this Plan as the
Committee may specify.

              6.2. The price per share of Common Stock at which an Incentive
Stock Option granted under this Plan may be exercised shall not be less than one
hundred percent (100%) of the Fair Market Value of the Common Stock on the Date
of Grant. The price per share of Common Stock for Options other than Incentive
Stock Options may in the discretion of the Committee be less than one hundred
percent (100%). Notwithstanding the foregoing, in the case of an Incentive Stock
Option granted to an

                                       4
<PAGE>   5

Employee who, at the time of grant, is a Ten Percent Shareholder, the exercise
price per share shall not be less than one hundred and ten percent (110%) of the
Fair Market Value of the Common Stock on the date on which the Option is
granted.

              6.3. The Option Period shall be determined by the Committee and
specifically set forth in the Agreement; provided, however, that an Option shall
not be exercisable after ten years (five years in the case of an Incentive Stock
Option granted to a Ten-Percent Stockholder) from its Date of Grant.

              6.4. The Committee, in its discretion, may provide in an Agreement
for the right of a Participant to surrender to the Company an Option (or a
portion thereof) that has become exercisable and to receive upon such surrender,
without any payment to the Company (other than required tax withholding amounts)
that number of Shares (equal to the highest whole number of Shares) having an
aggregate fair market value as of the date of surrender equal to that number of
Shares subject to the Option (or portion thereof) being surrendered multiplied
by an amount equal to the excess of (i) the Fair Market Value on the date of
surrender over (ii) the Option Price, plus an amount of cash equal to the fair
market value of any fractional Share to which the Participant would be entitled
but for the parenthetical above relating to whole number of Shares. Any such
surrender shall be treated as the exercise of the Option (or portion thereof).

       7. Rights.

              7.1. Rights granted under the Plan shall be evidenced by an
Agreement specifying the terms and conditions of the grant.

              7.2. A Right may be granted under the Plan: (a) in connection
with, and at the same time as, the grant of an Option under the Plan; (b) by
amendment of an outstanding Option granted under the Plan; or (c) independently
of any Option granted under the Plan. A Right described in clause (a) or (b) of
the preceding sentence is a Related Right. A Related Right may, in the
Committee's discretion, apply to all or any portion of the Shares subject to the
Related Option.

              7.3. A Right may be exercised in whole or in part as provided in
the applicable Agreement, and, subject to the terms of the Agreement, entitles a
Participant to receive, without payment to the Company (but subject to required
tax withholding), either cash or that number of Shares (equal to the highest
whole number of Shares), or a combination thereof, in an amount or having a fair
market value determined as of the Date of Exercise not to exceed the number of
Shares subject to the portion of the Right exercised multiplied by an amount
equal to the excess of (a) Fair Market Value on the Date of Exercise of the
Right (or such amount in excess of such Fair Market Value as may be specified by
the Committee) over (b) either (i) the Fair Market Value on the Date of Grant of
the Right if it is not a Related Right, or (ii) the Option Price as provided in
the Related Option if the Right is a Related Right.

                                       5
<PAGE>   6

              7.4. The Right Period shall be determined by the Committee and
specifically set forth in the Agreement; provided, however, that (a) a Right
will expire no later than the earlier of (i) ten years from the Date of Grant,
or (ii) in the case of a Related Right, the expiration of the Related Option;
and (b) a Right that is a Related Right to an Incentive Stock Option may be
exercised only when and to the extent the Related Option is exercisable.

              7.5. The exercise, in whole or in part, of a Related Right shall
cause a reduction in the number of Shares subject to the Related Option equal to
the number of Shares with respect to which the Related Right is exercised.
Similarly, the exercise, in whole or in part, of a Related Option shall cause a
reduction in the number of Shares subject to the Related Right equal to the
number of Shares with respect to which the Related Option is exercised.

       8. Exercise of Options and Rights.

              8.1. An Option or Right may, subject to the terms of the
applicable Agreement under which it was granted, be exercised in whole or in
part by the delivery to the Company of written notice of the exercise, in such
form as the Committee may prescribe, accompanied, in the case of an Option, by
(a) a full payment for the Shares with respect to which the Option is exercised
or (b) irrevocable instructions to a broker to deliver promptly to the Company
cash equal to the exercise price of the Option. To the extent provided in the
applicable Agreement, payment may be made in whole or in part by delivery
(including constructive delivery) of Shares (provided that such Shares, if
acquired pursuant to an option granted hereunder or under any other plan
maintained by the Company or any Affiliate, have been held by the Participant
for at least six (6) months) valued at Fair Market Value on the Date of Exercise
or by delivery of a promissory note as provided in Section 8.2 hereof.

              8.2. To the extent provided in an Agreement and permitted by
applicable law, the Committee may accept as partial payment of the Option Price
a promissory note executed by the Participant evidencing his or her obligation
to make future cash payment thereof. Promissory notes made pursuant to this
Section 8.2 shall be payable upon such terms as may be determined by the
Committee, shall be secured by a pledge of the Shares received upon exercise of
the Option, or other securities the Committee may deem to be acceptable for such
purposes, and shall bear interest at a rate fixed by the Committee.

              8.3. Awards granted under this Plan shall not be transferable
except by will and the laws of descent and distribution, except to the extent
provided in an Agreement.

                                       6
<PAGE>   7

       9. Restricted Stock Awards.

              9.1. Restricted Stock awards under this Plan shall consist of
Shares that are restricted as to transfer, subject to forfeiture and subject to
such other terms and conditions as may be determined by the Committee. Such
terms and conditions may provide, in the discretion of the Committee, for the
lapse of such transfer restrictions and forfeiture provisions to be contingent
upon the achievement of one or more specified Performance Goals.

              9.2. Restricted Stock awards under this Plan shall be evidenced by
Agreements specifying the terms and conditions of the Award. Each Agreement
evidencing an Award of Restricted Stock shall contain the following:

                     (a) prohibitions against the sale, assignment, transfer,
exchange, pledge, hypothecation, or other encumbrance of (i) the Shares awarded
as Restricted Stock, (ii) the right to vote the Shares, and (iii) the right to
receive dividends thereon, in each case during the restriction period applicable
to the Shares; provided, however, that the Participant shall have all the other
rights of a stockholder including without limitation the right to receive
dividends and the right to vote the Shares;

                     (b) a requirement that each certificate representing Shares
of Restricted Stock shall be deposited with the Company, or its designee, and
shall bear the following legend:

                     "This certificate and the shares of stock represented
                     hereby are subject to the terms and conditions (including
                     the risks of forfeiture and restrictions against transfer)
                     contained in the Lifeclinic Holding Corporation 2000
                     Long-Term Incentive Plan, and an Agreement entered into
                     between the registered owner and Lifeclinic Holding
                     Corporation. Release from such terms and conditions shall
                     be made only in accordance with the provisions of this Plan
                     and the Agreement, a copy of each of which is on file in
                     the office of the Secretary of Lifeclinic Holding
                     Corporation."

                     (c) the terms and conditions upon which any restrictions
applicable to Shares of Restricted Stock shall lapse and new certificates free
of the foregoing legend shall be issued to the Participant or the Participant's
legal representative; and

                     (d) such other terms, conditions and restrictions as the
Committee in its discretion may specify, including without limitation terms that
condition the lapse of forfeiture provisions and transfer restrictions upon the
achievement of one or more specified Performance Goals.

                                       7
<PAGE>   8

       10. Incentive Share Awards. Incentive Share Awards under this Plan shall
be evidenced by an Agreement specifying the terms and conditions of such Award.
Incentive Share Awards shall provide for the issuance of Shares to a Participant
at such times and subject to such terms and conditions as determined by the
Committee, including without limitation terms that condition the issuance of
Shares upon the achievement of one or more specified Performance Goals.

       11. Performance Awards. Performance Awards granted under this Plan shall
be evidenced by an Agreement specifying the terms and conditions of such Award.
Performance Awards shall become payable on account of attainment of one or more
specified Performance Goals. Performance Awards may be paid by the delivery of
Common Stock or cash, or any combination of Common Stock and cash, as specified
in the Agreement. For purposes of Section 5.2 hereof, a Performance Award shall
be deemed to cover a number of Shares equal to the sum of (a) the maximum number
of Shares that may be issued upon payment of the Award, and (b) to the extent
the Award is not payable in Shares, a number of Shares equal to the quotient
obtained by dividing the maximum dollar amount of the Award that is not payable
in Shares by the Fair Market Value of a Share as of the Date of Grant of the
Award, rounded to the next highest whole number.

       12. Capital Adjustments. In the event of any change in the outstanding
Common Stock by reason of any stock dividend, split-up, spin-off,
recapitalization, reclassification, combination or exchange of shares, merger,
consolidation, liquidation or the like, the Board may, in its discretion,
provide for a substitution for or adjustment in (a) the number and class of
Shares subject to outstanding Options, Rights and Awards of Restricted Stock,
Incentive Share Awards or Performance Awards, (b) the Option Price of Options
and the base price upon which payments under Rights that are not Related Rights
are determined, (c) the aggregate number and class of Shares for which Awards
thereafter may be made under this Plan, and (d) the maximum number of Shares
with respect to which an Eligible Person may be granted Awards during the period
specified in Section 5.2.

       13. Termination or Amendment. The Board may amend, alter or terminate
this Plan in any respect at any time; provided, however, that, after this Plan
has been approved by the stockholders of the Company, no amendment, alteration
or termination of this Plan shall be made by the Board without approval of (a)
the Company's stockholders to the extent stockholder approval of the amendment
is required by applicable law or regulations or the requirements of the
principal exchange or interdealer quotation system on which the Common Stock is
listed or quoted, if any, and (b) each affected Participant if such amendment,
alteration or termination would adversely affect such Participant's rights or
obligations under any Award made prior to the date of such amendment, alteration
or termination.

       14. Modification, Extension, Renewal, Substitution.

                                       8
<PAGE>   9

              14.1. Subject to the terms and conditions of this Plan, the
Committee may modify, extend or renew outstanding Options and Rights, or accept
the surrender of outstanding Options and Rights granted under this Plan or
options and stock appreciation rights granted under any other plan of the
Company or an Affiliate (to the extent not theretofore exercised), and authorize
the granting of new Options and Rights pursuant to this Plan in substitution
therefor. Any substituted Options or Rights may specify a lower exercise price
than the surrendered options and stock appreciation rights, a longer term than
the surrendered options and stock appreciation rights, or have any other
provisions that are authorized by this Plan. Subject to the terms and conditions
of this Plan, the Committee may modify the terms of any outstanding Awards.
Notwithstanding the foregoing, however, no modification of an Award shall,
without the consent of the Participant, alter or impair any of the Participant's
rights or obligations under such Award.

              14.2. Anything contained herein to the contrary notwithstanding,
Options, Rights, Restricted Stock Awards, Incentive Share Awards and Performance
Awards may, at the discretion of the Committee, be granted under this Plan in
substitution for options and such other awards covering capital stock of another
corporation which is merged into, consolidated with, or all or a substantial
portion of the property or stock of which is acquired by, the Company or one of
its Affiliates. The terms and conditions of the substitute Awards so granted may
vary from the terms and conditions set forth in this Plan to such extent as the
Committee may deem appropriate in order to conform, in whole or part, to the
provisions of the awards in substitution for which they are granted. Shares
covered by such substitute Awards granted hereunder shall not be counted toward
the Share limits imposed by Section 5.2, except to the extent it is determined
by the Committee that counting such Shares is required in order for Awards
hereunder to be eligible to qualify as "performance-based compensation" within
the meaning of Section 162(m) of the Code.

       15. Effectiveness of this Plan. This Plan and any amendments hereto
requiring stockholder approval pursuant to Section 13 are subject to approval by
vote of the stockholders of the Company at the next annual or special meeting of
stockholders following adoption by the Board. Subject to such stockholder
approval, this Plan and any amendments hereto are effective on the date on which
they are adopted by the Board.

       16. Withholding. The Company's obligation to deliver Shares or pay any
amount pursuant to the terms of any Award hereunder shall be subject to
satisfaction of applicable federal, state and local tax withholding
requirements. To the extent provided in the applicable Agreement and in
accordance with rules prescribed by the Committee, a Participant may satisfy any
such withholding tax obligation by any of the following means or by a
combination of such means: (a) tendering a cash payment, (b) authorizing the
Company to withhold Shares otherwise issuable to the Participant, or (c)
delivering to the Company already owned and unencumbered Shares.

       17. Term of this Plan. Unless sooner terminated by the Board pursuant to
Section 13, this Plan shall terminate on the date that is ten years from the
date this Plan is

                                       9
<PAGE>   10

approved by the sole shareholder of the Company and no Awards may be granted or
awarded after such date. The termination of this Plan shall not affect the
validity of any Award outstanding on the date of termination.

       18. Indemnification of Committee. In addition to such other rights of
indemnification as they may have as Directors or as members of the Committee,
the members of the Committee shall be indemnified by the Company against all
reasonable expenses, including attorneys' fees, actually and reasonably incurred
in connection with the defense of any action, suit or proceeding, or in
connection with any appeal therein, to which they or any of them may be a party
by reason of any action taken or failure to act under or in connection with this
Plan or any Award hereunder, and against all amounts reasonably paid by them in
settlement thereof or paid by them in satisfaction of a judgment in any such
action, suit or proceeding, if such members acted in good faith and in a manner
which they believed to be in, and not opposed to, the best interests of the
Company.

       19. General Provisions.

              19.1. The establishment of this Plan shall not confer upon any
Eligible Person any legal or equitable right against the Company, any Affiliate
or the Committee, except as expressly provided in this Plan.

              19.2. This Plan does not constitute inducement or consideration
for the employment or service of any Eligible Person, nor is it a contract
between the Company or any Affiliate and any Eligible Person. Participation in
this Plan shall not give a an Eligible Person any right to be retained in the
service of the Company or any Affiliate.

              19.3. Neither the adoption of this Plan nor its submission to the
stockholders, shall be taken to impose any limitations on the powers of the
Company or its Affiliates to issue, grant, or assume options, warrants, rights,
or restricted stock, or other awards otherwise than under this Plan, or to adopt
other stock option, restricted stock, or other plans or to impose any
requirement of stockholder approval upon the same.

              19.4. The interests of any Eligible Person under this Plan are not
subject to the claims of creditors and may not, in any way, be assigned,
alienated or encumbered except as provided in an Agreement.

              19.5. This Plan shall be governed, construed and administered in
accordance with the laws of the State of Washington.

              19.6. The Committee may require each person acquiring Shares
pursuant to Awards hereunder to represent to and agree with the Company in
writing that such person is acquiring the Shares without a view to distribution
thereof. The certificates for such Shares may include any legend which the
Committee deems appropriate to reflect any restrictions on transfer. All
certificates for Shares issued pursuant to this Plan shall

                                       10
<PAGE>   11

be subject to such stock transfer orders and other restrictions as the Committee
may deem advisable under the rules, regulations and other requirements of the
Securities and Exchange Commission, any stock exchange upon which the Common
Stock is then listed or interdealer quotation system upon which the Common Stock
is then quoted, and any applicable federal or state securities laws. The
Committee may place a legend or legends on any such certificates to make
appropriate reference to such restrictions.

              19.7. The Company shall not be required to issue any certificate
or certificates for Shares with respect to Awards under this Plan, or record any
person as a holder of record of such Shares, without obtaining, to the complete
satisfaction of the Committee, the approval of all regulatory bodies deemed
necessary by the Committee, and without complying to the Board's or Committee's
complete satisfaction, with all rules and regulations, under federal, state or
local law deemed applicable by the Committee.

                                       11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00013-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00013-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00013-of-00352.parquet"}]]